Enhanced Oncolytic Activity of Vesicular Stomatitis Virus Encoding SV5-F Protein Against Prostate Cancer

Journal of Urology

Volumn 183, Issue 4, 2010, Pages 1611-1618

  Chang, Guimin ^a   Xu, Shuping ^a   Watanabe, Makiko ^a   Jayakar, Himangi R ^a   Whitt, Michael A ^a   Gingrich, Jeffrey R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; DNA; prostate; prostatic neoplasms; recombinant; viruses

Indexed keywords

ANTINEOPLASTIC AGENT; GREEN FLUORESCENT PROTEIN; SIMIAN PARAINFLUENZA VIRUS 5 F PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; GEL ELECTROPHORESIS; HAMSTER; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR VOLUME; VESICULAR STOMATITIS VIRUS;

ANIMALS; CELL LINE, TUMOR; HUMANS; MALE; MICE; ONCOLYTIC VIROTHERAPY; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; VESICULOVIRUS; VIRAL FUSION PROTEINS;

EID: 77949333823     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.12.005     Document Type: Article

References (30)

1. O'Shea C.C. Viruses: tools for tumor target discovery, and agents for oncolytic therapies-an introduction. Oncogene 24 (2005) 7636
2. Barber G.N. Vesicular stomatitis virus as an oncolytic vector. Viral Immunol 17 (2004) 516
3. Ebert O., Harbaran S., Shinozaki K., et al. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice. Cancer Gene Ther 12 (2005) 350
4. Shinozaki K., Ebert O., and Woo S.L. Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV. Hepatology 41 (2005) 196
5. Gaddy D.F., and Lyles D.S. Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways. J Virol 79 (2005) 4170
6. Chesler D.A., and Reiss C.S. The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev 13 (2002) 441
7. Rose J.K., and Whitt M.A. Rhabdoviridae: the viruses and their replication. In: Knipe D., and Howley P.M. (Eds). Field's Virology. 4th ed. vol 1 (2001), Lippincott Williams & Wilkins, Philadelphia 1221-1244
8. Ahmed M., Cramer S.D., and Lyles D.S. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses. Virology 330 (2004) 34
9. Steinhoff U., Muller U., Schertler A., et al. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J Virol 69 (1995) 2153
10. Bi Z., Barna M., Komatsu T., et al. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J Virol 69 (1995) 6466
11. Lundh B., Kristensson K., and Norrby E. Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses. Neuropathol Appl Neurobiol 13 (1987) 111
12. van den Pol A.N., Dalton K.P., and Rose J.K. Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. J Virol 76 (2002) 1309
13. Duntsch C.D., Zhou Q., Jayakar H.R., et al. Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model. J Neurosurg 100 (2004) 1049
14. Blickwede M., Dolz G., Herrero M.V., et al. Neutralizing antibodies against vesicular stomatitis viruses (serotypes New Jersey and Indiana) in horses in Costa Rica. J Vet Diagn Invest 14 (2002) 438
15. Bateman A.R., Harrington K.J., Kottke T., et al. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells. Cancer Res 62 (2002) 6566
16. Ebert O., Shinozaki K., Kournioti C., et al. Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer. Cancer Res 64 (2004) 3265
17. Shin E.J., Chang J.I., Choi B., et al. Fusogenic vesicular stomatitis virus for the treatment of head and neck squamous carcinomas. Otolaryngol Head Neck Surg 136 (2007) 811
18. Paterson R.G., Russell C.J., and Lamb R.A. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology 270 (2000) 17
19. Jeetendra E., Robison C.S., Albritton L.M., et al. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol 76 (2002) 12300
20. Foster B.A., Gingrich J.R., Kwon E.D., et al. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 57 (1997) 3325
21. Takada A., Robison C., Goto H., et al. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94 (1997) 14764
22. Lawson N.D., Stillman E.A., Whitt M.A., et al. Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 92 (1995) 4477
23. Steiner M.S., Zhang X., Wang Y., et al. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer Res 60 (2000) 4419
24. Zhang Y., Liu X.X., Zhang B., et al. Antitumor effect of antisense ODC adenovirus on human prostate cancer cells. Prostate Cancer Prostatic Dis 8 (2005) 280
25. Paterson R.G., Hiebert S.W., and Lamb R.A. Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A 82 (1985) 7520
26. Huang T.G., Ebert O., Shinozaki K., et al. Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice. Mol Ther 8 (2003) 434
27. Miller M.A., Lavine C.L., Klas S.D., et al. Recombinant replication-restricted VSV as an expression vector for murine cytokines. Protein Expr Purif 33 (2004) 92
28. Klas S.D., Robison C.S., Whitt M.A., et al. Adjuvanticity of an IL-12 fusion protein expressed by recombinant deltaG-vesicular stomatitis virus. Cell Immunol 218 (2002) 59
29. Gomez-Trevino A., Castel S., Lopez-Iglesias C., et al. Effects of adenovirus-mediated SV5 fusogenic glycoprotein expression on tumor cells. J Gene Med 5 (2003) 483
30. Bateman A., Bullough F., Murphy S., et al. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res 60 (2000) 1492